Curcumin-Based β-Diketo Ligands for Ga<sup>3+</sup>: Thermodynamic Investigation of Potential Metal-Based Drugs
Curcumin is known for its therapeutic properties; among these, antioxidant, anti-inflammatory and anti-cancer ones stand out. Besides, curcumin metal complexes have shown widespread application in medicine and can be exploited as lead structures for developing metal-based drugs. Unfortunately, curcu...
Saved in:
Main Authors: | Matteo Mari (Author), Debora Carrozza (Author), Gianluca Malavasi (Author), Ettore Venturi (Author), Giulia Avino (Author), Pier Cesare Capponi (Author), Michele Iori (Author), Sara Rubagotti (Author), Silvia Belluti (Author), Mattia Asti (Author), Erika Ferrari (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2022-07-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Automated GMP Production and Preclinical Evaluation of [<sup>68</sup>Ga]Ga-TEoS-DAZA and [<sup>68</sup>Ga]Ga-TMoS-DAZA
by: Julia Greiser, et al.
Published: (2022) -
[<sup>68</sup>Ga]Ga-DOTA-TOC: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging
by: Ute Hennrich, et al.
Published: (2020) -
[<sup>68</sup>Ga]Ga-PSMA-11: The First FDA-Approved <sup>68</sup>Ga-Radiopharmaceutical for PET Imaging of Prostate Cancer
by: Ute Hennrich, et al.
Published: (2021) -
Liquid Chromatography ICP-MS to Assess the Stability of <sup>175</sup>Lu- and <sup>nat</sup>Ga-Based Tumor-Targeting Agents towards the Development of <sup>177</sup>Lu- and <sup>68</sup>Ga-Labeled Radiopharmaceuticals
by: Rahel H. Wallimann, et al.
Published: (2024) -
<sup>68</sup>Ga-Radiolabeling and Pharmacological Characterization of a Kit-Based Formulation of the Gastrin-Releasing Peptide Receptor (GRP-R) Antagonist RM2 for Convenient Preparation of [<sup>68</sup>Ga]Ga-RM2
by: Adrien Chastel, et al.
Published: (2021)